리사타 테라퓨틱스(LSTA)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.09 (-3.54%), 시가총액 $0.03B, 52주 범위 $1.86 ~ $5.04.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
리사타 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
리사타 테라퓨틱스의 현재 주가는 $1.09 (-3.54%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
리사타 테라퓨틱스의 시가총액은 약 $0.03B입니다.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its